Oncolytics Biotech Inc (ONCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,782 | -9,292 | -4,657 | -23,142 | -17,367 |
| Depreciation Amortization | 206 | 138 | 68 | 309 | 239 |
| Accounts receivable | N/A | N/A | -15 | N/A | N/A |
| Other Working Capital | 1,102 | -774 | -595 | 2,582 | 3,297 |
| Other Operating Activity | 4,958 | 1,274 | 673 | 571 | -184 |
| Operating Cash Flow | $-13,516 | $-8,654 | $-4,525 | $-19,680 | $-14,015 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | N/A | N/A | -174 | -171 |
| Investing Cash Flow | $-5 | $N/A | $N/A | $-174 | $-171 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,237 | N/A | N/A | 47 | 48 |
| Other Financing Activity | 8,942 | 8,143 | 4,102 | 4,796 | 2,369 |
| Financing Cash Flow | $11,180 | $8,143 | $4,102 | $4,843 | $2,417 |
| Exchange Rate Effect | -264 | -441 | -22 | 1,167 | 544 |
| Beginning Cash Position | 11,572 | 11,526 | 11,102 | 25,479 | 25,591 |
| End Cash Position | 8,966 | 10,575 | 10,657 | 11,635 | 14,365 |
| Net Cash Flow | $-2,606 | $-952 | $-445 | $-13,844 | $-11,225 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,516 | -8,654 | -4,525 | -19,680 | -14,015 |
| Capital Expenditure | -5 | N/A | N/A | -174 | -171 |
| Free Cash Flow | -13,521 | -8,654 | -4,525 | -19,854 | -14,186 |